4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-25-027205
Chief Financial Officer returned 1,601 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Carter Robert Ross Chief Financial Officer | 2025-05-21 | Returned to the company | −1,601 | $2.68 | $4,283 | 235,174 | D |
Loading xslF345X05/wk-form4_1747937561.xml…